T1	intervention 299 308	tamoxifen
T2	condition 334 373	endometrium and gynaecological symptoms
T3	No-of-participants 386 388	96
T4	intervention-participants 438 440	45
T5	control 445 452	placebo
T6	control-participants 461 463	51
T7	duration 475 482	5 years
T8	duration 654 679	between 2/1995 and 7/2009
T9	location 683 690	Finland
T10	outcome 882 908	discontinued the treatment
T11	intervention-value 935 938	44%
T12	control-value 946 949	22%
T13	outcome 1071 1092	endometrial thickness
T14	outcome 1317 1370	referrals to hospitals due to gynaecological findings
T15	outcome 1551 1571	discontinuation rate
